Erratum: Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: Observational retrospective cohort study (Nephrology Dialysis Transplantation (2012) 27:9 (3575-3581) DOI: 10.1093/ndt/gfs081);Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: Observational retrospective cohort study

Nephrology Dialysis Transplantation

Volumn 27, Issue 9, 2012, Pages 3575-3581

  Dixon, John J ^a   Steele, Maggi ^a   Makanjuola, A David ^a  

^a ST HELIER HOSPITAL   (United Kingdom)

Author keywords

antibiotic resistance; haemodialysis catheter; line locks

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; GENTAMICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; CATHETER INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; ENTEROBACTER; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

EID: 84865711013     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs576     Document Type: Erratum

References (32)

1. Taylor G, Gravel D, Johnston L et al. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 2004; 32: 155-160.
2. Engemann JJ, Friedman JY, Reed SD et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 2005; 26: 534-539.
3. Kesser M, Hoen B, Mayeux D et al. Bacteraemia in patients on chronic haemodialysis. A multicenter prospective study. Nephron 1993; 64: 95-100.
4. Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
5. Poole CV, Carlton D, Bimbo L et al. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transpl 2004; 19: 1237-1244.
6. Fux CA, Costerton JW, Stewarts PS et al. Survival strategies of infectious biofilms. Trends Microbiol 2005; 13: 34-40.
7. Fluck R, Kumwanda M. Renal Association. Vascular access for haemodialysis guidelines. http:www.renal.org/Clinical/GuidelinesSection/VascularAccess.aspx. Accessed 6 October 2010.
8. Bleyer AJ. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin J Am Soc Nephrol 2007; 2: 1073-1078.
9. House of Lords Select Committees on Science and Technology. Seventh Report: Resistance to Antibiotics and Other Antimicrobial Agents. London, UK: HMSO, 1998.
10. Berns JS. Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dial 2003; 16: 30-37.
11. Landry DL, Braden GL, Gobeille SL et al. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin-lock catheter prophylaxis. Clin J Am Soc Nephrol 2010; 5: 1799-1804.
12. McGowan JE, Gerding DN. Does antibiotic restriction prevent resistance?. New Horizons 1996; 4: 370-376.
13. Department of Health Standing Medical Advisory Committee Subgroup on Antimicrobial Resistance. Occasional Paper: The Path of Least Resistance London, UK: The Stationary Office, 1998.
14. Boorgu R, Dubrow AJ, Levin NWet al. Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device. ASAIO J 2000; 46: 767-770.
15. Kim SH, Song KI, Chang JWet al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomised clinical trial. Kidney Int 2006; 69: 161-164.
16. Saxena AK, Panhotra BR, Sundaram DS et al. Enhancing the survival of tunnelled hemodialysis catheters using an antibiotic lock in the elderly. A randomised-double-blind, clinical trial. Nephrology (Carlton) 2006; 11: 299-305.
17. Saxena AK, Panhotra BR, Sundaram DS et al. Tunnelled catheters' outcome optimisation among diabetics on dialysis through antibiotic-lock placement. Kidney Int 2006; 70: 1629-1635.
18. Al-Hweish AK, Abdul-Rahman IS. Successful prevention of tunnelled, central catheter infection by antibiotic lock therapy using vancomycin and gentamicin. Saudi J Kidney Dis Transpl 2007; 18: 239-247.
19. Dogra GK, Herson H, Hutchison B et al. Prevention of tunnelled hemodialysis-related infections using catheter-restricted filling with gentamicin and citrate: a randomised controlled study. J Am Soc Nephrol 2002; 13: 2133-2139.
20. McIntyre CW, Hulme LJ, Taal M et al. Locking of tunnelled hemodialysis catheters with gentamicin and heparin. Kidney Int 2004; 6: 801-805.
21. Bastani B, Amin K, Herr A. Prolonged stability of stored vancomycin, gentamicin, and heparin for use in the antibiotic-lock technique. ASAIO J 2005; 51: 761-763.
22. Yahav D, Rosen-Zvi B, Gafter-Gvili A et al. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008; 47: 83-93.
23. Amore A, Coppe R. Effect on the immune response. In: Davison AM, Cameron JS, Grunfeld J-P et al. (eds). The Oxford Textbook of Nephrology. 3rd edn. Oxford: Oxford University Press, 2005, pp.1121-1138.
24. Saxena AK, Panhotra BR, Naguib M. Sudden irreversible sensoryneural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-lock. Pharmacotherapy 2002; 22: 105-108.
25. Sunger M, Eryuksel E, Yavas S et al. Exit of catheter lock solutions from double lumen acute dialysis catheters-an in vitro study. Nephrol Dial Transpl 2007; 22: 3533-3537.
26. Onder AM, Billings A, Chander J et al. PREFABL: predictors of failure of antibiotic locks for the treatment of catheter-related bacteraemia. Nephrol Dial Transpl 2010; 25: 3686-3693.
27. Vandecasteele SJ, Boelaert JR, De Vriese AS. Staphylococcus aureus infection in hemodialysis: what a nephrologist should know. Clin J Am Soc Nephrol 2009; 4: 1388-1400.
28. Rieg S, Peyeri-Hoffmann G, de With K et al. Mortality of S. Aureus bacteremia and infectious diseases specialist consultation-a study of 521 patients in Germany. J Infect 2009; 59: 232-239.
29. Peacock SJ, Curtlist N, Berendt AR et al. Outcome following haemodialysis catheter-related Staphylococcus aureus bacteraemia. J Hosp Infec 1999; 41: 223-228.
30. Maya ID, Carlton A, Estrade E et al. Treatment of dialysis catheterrelated Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am J Kid Dis 2007; 50: 289-295.
31. Fraser SL, Arnett M. Enterobacter infectionshttp://emedicine.medscape. com/article/216845-overview. Accessed 10 April 2011.
32. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13: 686-707.